Top brokers name 3 ASX shares to sell today

Brokers are bearish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday I looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three ASX shares that have just been given sell ratings by brokers are listed below. Here's why these brokers are bearish on them:

Nanosonics Ltd (ASX: NAN)

According to a note out of Citi, its analysts have retained their sell rating but lifted their price target on this infection prevention company's shares to $5.00. While Nanosonics delivered a full year result ahead of Citi's expectations, it wasn't enough for a change of rating. The broker continues to believe its shares are overvalued. It also doesn't believe the market is taking into account execution risks for new product launches. The Nanosonics share price was fetching $7.01 on Thursday.

Platinum Asset Management Ltd (ASX: PTM)

A note out of Macquarie reveals that its analysts have retained their underperform rating and cut their price target on this fund manager's shares to $3.85. Platinum's FY 2021 results fell a touch short of Macquarie's expectations due to higher costs. Outside this, the broker highlights that Platinum's international funds are underperforming, which it feels will put pressure on fund flows. The Platinum share price fell heavily on Thursday and ended the day at $3.94.

Reece Ltd (ASX: REH)

Another note out of Macquarie reveals that its analysts have retained their underperform rating and cut their price target on this plumbing parts company's shares to $18.80. This follows the release of a full year result that was just ahead of expectations. However, the broker was disappointed with the performance of Reece's US business. Combined with its shares trading on lofty multiples, Macquarie is holding firm with its underperform rating. The Reece share price has pulled back significantly since its result but is still trading above the broker's price target at $20.64.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »